MORGAN STANLEY

Position in ENTX — Entera Bio Ltd.

CIK 895421 NEW YORK, NY

Position in ENTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$444

-$156 QoQ

Shares Held

400

-60.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#23

of 26 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. ENTX ranks #482 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$444	400	-60.0%	Shares	Defined	2026-05-15
2023-12-31	$600	1,000	0.0%	Shares	Defined	2024-08-16
2023-09-30	$725	1,000	-9.1%	Shares	Defined	2023-11-15
2023-06-30	$927	1,100	+10.0%	Shares	Defined	2023-08-14
2023-03-31	$1,160	1,000	0.0%	Shares	Defined	2023-05-15
2022-12-31	$730	1,000	-97.2%	Shares	Defined	2023-02-14
2022-09-30	$37,612	36,166	+1207.5%	Shares	Defined	2022-11-14
2022-06-30	$3,678	2,766	-44.2%	Shares	Defined	2022-10-27
2022-03-31	$14,223	4,956	-17.0%	Shares	Defined	2022-10-27
2021-12-31	$16,799	5,968	+11.0%	Shares	Defined	2022-02-14
2021-09-30	$25,330	5,378	+145.6%	Shares	Defined	2021-11-15
2021-06-30	$13,096	2,190	—	Shares	Defined	2021-08-23
No filing history on record for this holder in this stock.